Zoetis Inc.

ZTS · XNYS

CIK 1555280fmd_02APXP1SBQS0D8Q0MBTM9DN6DDManufacturing · Pharmaceutical PreparationsTemplate: Standard

Coverage: Jan 01, 2011 to Sep 30, 2026, 61 periods

Income Statement · Annual · Millions · USD
Line item	FY2016	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Total revenues	4,888	5,307	5,825	6,260	6,675	7,776	8,080	8,544	9,256	9,467
Cost of revenue	1,666	1,775	1,911	1,992	2,057	2,303	2,454	2,561	2,719	2,666
Gross profit	3,222	3,532	3,914	4,268	4,618	5,473	5,626	5,983	6,537	6,801
Research and development	376	382	432	457	463	508	539	614	686	698
Selling, general and administrative	1,364	1,334	1,484	1,638	1,726	2,001	2,009	2,151	2,318	2,378
Interest expense	166	175	206	223	231	224	221	239	225	222
Other non-operating income (expense)	2	(6)	83	57	(17)	(48)	(40)	159	19	36
Income before taxes	1,228	1,525	1,690	1,801	1,996	2,488	2,656	2,936	3,133	3,360
Income tax expense	409	663	266	301	360	454	545	596	637	687
Net income from continuing operations	819	862	1,424	1,500	1,636	2,034	2,111	2,340	2,496	2,673
Net income	821	864	1,428	1,500	1,638	2,037	2,114	2,344	2,486	2,673